Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.

Krivtsov, A V

Cell of origin determines clinically relevant subtypes of MLL-rearranged AML. [electronic resource] - Leukemia Apr 2013 - 852-60 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1476-5551

10.1038/leu.2012.363 doi


Adult
Animals
Antineoplastic Agents--pharmacology
Cytarabine--pharmacology
Gene Expression Profiling
Histone-Lysine N-Methyltransferase
Humans
Leukemia, Myeloid, Acute--genetics
Mice
Mice, Inbred C57BL
Myeloid-Lymphoid Leukemia Protein--genetics